tradingkey.logo

Genpact Ltd

G
40.390USD
+2.690+7.14%
Close 02/06, 16:00ETQuotes delayed by 15 min
6.96BMarket Cap
12.71P/E TTM

Genpact Ltd

40.390
+2.690+7.14%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Genpact Ltd

Currency: USD Updated: 2026-02-06

Key Insights

Genpact Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 28 out of 156 in the Professional & Commercial Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 49.77.In the medium term, the stock price is expected to remain stable.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Genpact Ltd's Score

Industry at a Glance

Industry Ranking
28 / 156
Overall Ranking
102 / 4521
Industry
Professional & Commercial Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Genpact Ltd Highlights

StrengthsRisks
Genpact Limited is an agentic and advanced technology solutions company. The Company leverages process intelligence and artificial intelligence to deliver measurable outcomes. The Company's segments include Financial Services, Consumer and Healthcare, and High Tech and Manufacturing. Its Financial Services segment covers services the Company provides to clients in the banking, capital markets and insurance sectors. Its core operations services for these clients include customer onboarding, customer service, collections, and others. Its Consumer and Healthcare segment covers services it provides to clients in the consumer goods, retail, life sciences and healthcare sectors. The core operations services it provides to these clients include demand generation, sensing and planning, supply chain planning and management, and others. The Company's High Tech and Manufacturing segment covers services it provides to clients in the high-tech hardware, high-tech software and manufacturing sectors.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 21.12%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 21.12%.
Fairly Valued
The company’s latest PE is 12.71, at a medium 3-year percentile range.
Held by James Simons
Star Investor James Simons holds 532.00K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.45.

Analyst Rating

Based on 14 analysts
Buy
Current Rating
49.773
Target Price
+32.02%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Genpact Ltd is 8.56, ranking 19 out of 156 in the Professional & Commercial Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 1.32B, representing a year-over-year increase of 5.65%, while its net profit experienced a year-over-year increase of 0.83%.

Score

Industry at a Glance

Previous score
8.56
Change
0

Financials

9.50

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

8.29

Operational Efficiency

8.22

Growth Potential

7.62

Shareholder Returns

9.19

Genpact Ltd's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Genpact Ltd is 6.81, ranking 94 out of 156 in the Professional & Commercial Services industry. Its current P/E ratio is 12.71, which is 98.26% below the recent high of 25.20 and 31.95% above the recent low of 8.65.

Score

Industry at a Glance

Previous score
6.81
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 28/156
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Genpact Ltd is 7.29, ranking 98 out of 156 in the Professional & Commercial Services industry. The average price target is 51.50, with a high of 58.00 and a low of 42.00.

Score

Industry at a Glance

Previous score
7.29
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 14 analysts
Buy
Current Rating
49.773
Target Price
+32.02%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

78
Total
5
Median
8
Average
Company name
Ratings
Analysts
Genpact Ltd
G
14
PayPal Holdings Inc
PYPL
44
Block Inc
XYZ
44
Visa Inc
V
42
Fiserv Ord Shs
FISV
36
Fiserv Inc
FI
36
1
2
3
...
16

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Genpact Ltd is 7.09, ranking 71 out of 156 in the Professional & Commercial Services industry. Currently, the stock price is trading between the resistance level at 46.69 and the support level at 35.83, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.62
Change
0.47

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(1)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-1.522
Sell
RSI(14)
34.994
Neutral
STOCH(KDJ)(9,3,3)
19.027
Buy
ATR(14)
1.512
High Vlolatility
CCI(14)
-106.542
Sell
Williams %R
67.583
Sell
TRIX(12,20)
-0.517
Sell
StochRSI(14)
90.008
Buy
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
39.906
Buy
MA10
42.377
Sell
MA20
44.385
Sell
MA50
45.763
Sell
MA100
43.489
Sell
MA200
43.975
Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Genpact Ltd is 10.00, ranking 1 out of 156 in the Professional & Commercial Services industry. The latest institutional shareholding proportion is 108.45%, representing a quarter-over-quarter decrease of 0.35%. The largest institutional shareholder is The Vanguard, holding a total of 16.06M shares, representing 9.32% of shares outstanding, with 3.44% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
16.47M
-1.09%
BlackRock Institutional Trust Company, N.A.
13.70M
+5.40%
Fidelity Management & Research Company LLC
13.39M
-9.44%
Nalanda Capital Pte, Ltd.
12.69M
--
Victory Capital Management Inc.
5.32M
-46.35%
State Street Investment Management (US)
5.14M
+0.57%
Geode Capital Management, L.L.C.
4.22M
+15.81%
Fidelity Institutional Asset Management
5.03M
+4.94%
Dimensional Fund Advisors, L.P.
3.98M
+8.74%
Fiduciary Management, Inc.
3.63M
-14.24%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Professional & Commercial Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Genpact Ltd is 8.62, ranking 26 out of 156 in the Professional & Commercial Services industry. The company's beta value is 0.76. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
8.62
Change
0
Beta vs S&P 500 index
0.76
VaR
+2.49%
240-Day Maximum Drawdown
+29.16%
240-Day Volatility
+34.28%

Return

Best Daily Return
60 days
+15.89%
120 days
+15.89%
5 years
+15.89%
Worst Daily Return
60 days
-11.69%
120 days
-11.69%
5 years
-15.16%
Sharpe Ratio
60 days
+0.05
120 days
-0.79
5 years
+0.04

Risk Assessment

Maximum Drawdown
240 days
+29.16%
3 years
+33.88%
5 years
+43.05%
Return-to-Drawdown Ratio
240 days
-0.79
3 years
-0.10
5 years
-0.07
Skewness
240 days
-0.21
3 years
+0.88
5 years
+0.60

Volatility

Realised Volatility
240 days
+34.28%
5 years
+27.55%
Standardised True Range
240 days
+2.70%
5 years
+2.29%
Downside Risk-Adjusted Return
120 days
-118.15%
240 days
-118.15%
Maximum Daily Upside Volatility
60 days
+20.39%
Maximum Daily Downside Volatility
60 days
+26.49%

Liquidity

Average Turnover Rate
60 days
+0.97%
120 days
+0.95%
5 years
--
Turnover Deviation
20 days
+44.60%
60 days
+19.21%
120 days
+16.72%

Peer Comparison

Professional & Commercial Services
Genpact Ltd
Genpact Ltd
G
7.90 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brady Corp
Brady Corp
BRC
8.77 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
McGrath RentCorp
McGrath RentCorp
MGRC
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ennis Inc
Ennis Inc
EBF
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
RB Global Inc
RB Global Inc
RBA
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brinks Co
Brinks Co
BCO
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI